Niagen Bioscience (NAGE) Total Liabilities (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Total Liabilities data on file, last reported at $32.0 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 23.11% year-over-year to $32.0 million in Q1 2026; TTM through Mar 2026 was $32.0 million, a 23.11% increase from a year earlier, with the FY2025 full-year figure at $29.9 million, up 34.66% from the prior year.
• Total Liabilities for Q1 2026 stood at $32.0 million, up from $29.9 million in the prior quarter.
• Over the last five years, Total Liabilities for NAGE reached as high as $32.0 million in Q1 2026 and fell as low as $22.2 million in Q3 2024.
• Historically, Total Liabilities has averaged $26.0 million across 5 years, with a median of $26.0 million in 2025.
• Across the five-year window, Total Liabilities dropped 16.31% in 2024 and soared 34.66% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $25.4 million in 2022, then increased by 4.42% to $26.5 million in 2023, then fell by 16.31% to $22.2 million in 2024, then surged by 34.66% to $29.9 million in 2025, then gained by 7.12% to $32.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $32.0 million in Q1 2026, $29.9 million in Q4 2025, and $27.5 million in Q3 2025.